Diana Shipping is maintaining its $24.80 per share all-cash offer for Genco Holdings while simultaneously prosecuting a proxy fight aimed at replacing Genco's board before the June 18 annual meeting. The dual-track assault targets both Genco's defensive measures and its governance, a structure that lets Diana preserve optionality without raising the bid or walking away.
Diana is urging Genco shareholders to vote against a proposed equity incentive plan and a shareholder rights agreement—the formal name for a poison pill—while backing Diana's own slate of director nominees. The combination would strip Genco's current board of both dilution tools and seats, effectively handing control to the acquirer without a premium revision. Genco's proxy materials filed in late May disclosed the pill and equity plan as responses to Diana's unsolicited approach, standard M&A defense but now the center of a shareholder referendum.
The $24.80 price was first tabled in early April and has not moved despite Genco's shares trading near that level intermittently since. Diana's calculation appears to be that the bid is sufficient if governance changes, and that a contested vote is cheaper than a sweetened offer. Dry bulk shipping consolidation has accelerated since mid-2023, with fleet scale and cost synergies driving deals in the Panamax and Supramax segments where both companies operate. A combined entity would control approximately 135 vessels across those classes, creating the second-largest pure-play dry bulk operator by deadweight tonnage after Star Bulk Carriers.
The proxy contest's outcome will determine whether this becomes a negotiated transaction or a prolonged standoff. If Diana's nominees win even a partial board majority on June 18, Genco's ability to maintain the pill erodes and the equity plan dies, likely forcing the incumbent board to negotiate or step aside. If Genco's slate prevails and shareholders ratify the defenses, Diana faces a choice between raising the bid materially—likely to $26 or higher based on comparable shipping M&A premia—or abandoning the effort entirely. Neither company has filed updated proxy solicitations in the past week, meaning the current vote framework stands.
Allocators should watch for ISS and Glass Lewis recommendations, typically published 7 to 10 days before the meeting. Institutional shareholders holding roughly 68% of Genco's float will follow those guidelines in most cases, making the advisory firms' stance a reliable leading indicator. A second signal is any amended Diana filing that discloses a revised bid or withdrawal—required within four business days of a decision under Hart-Scott-Rodino and exchange rules. Fleet utilization data for May, due from both companies in early June, will show whether spot rates are supporting the strategic rationale for consolidation or undermining it.
The vote is June 18. The equity plan and pill are separate items, so partial outcomes are possible. Diana holds no Genco shares as of the last 13D filing, meaning it is waging this campaign entirely through public persuasion and ISS influence, not block ownership.